Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) has achieved a significant milestone by securing Depository Trust Company (DTC) eligibility for its common shares, a move that streamlines electronic clearing and settlement for U.S. investors. This approval is expected to enhance liquidity and simplify trading, making it easier for brokerage firms and investors to transact in the company's shares. CEO Louis Dron emphasized that DTC eligibility removes barriers for U.S. market participants, enabling more efficient processing of trades.
In a parallel development, Redwood AI has engaged InvestorBrandNetwork (IBN) to execute a comprehensive investor awareness campaign. The agreement covers editorial coverage, newsletter distribution, social media support, and podcast syndication through September 30, 2026, or until the allocated budget is exhausted. Redwood will pay IBN an aggregate cash fee of $114,000 for these services, with no securities issued as compensation. This strategic engagement aims to broaden the company's visibility among investors and the financial community.
Redwood AI leverages advanced artificial intelligence to accelerate research and development in chemistry, with applications in drug discovery, defense, and safety solutions. By combining expertise in chemistry, AI, and manufacturing, the company streamlines drug synthesis and scale-up processes. Its platform is designed to enable faster and more efficient development of new therapies and chemistry-driven applications.
The DTC eligibility and investor awareness initiatives represent key steps in Redwood AI's strategy to strengthen its market presence and facilitate access for U.S. investors. The company continues to focus on delivering innovative AI solutions to the chemistry R&D sector.
